All,Well the majority shareholders seem to be holding their nerve. No sudden moves as yet. Lets hope so. Can we also cut out some of the ongong negativity...Makes me anxious.GSL.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
